PROTIVITY LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR CATTLE
PROTIVITY LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR CATTLE
Authorised
- Mycoplasma bovis, strain N2805-1, Live
Product identification
Medicine name:
PROTIVITY LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR CATTLE
Protivity Lyophilisat et solvant pour suspension injectable
Protivity Lyofilisaat en oplosmiddel voor suspensie voor injectie
Protivity Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension
Active substance:
- Mycoplasma bovis, strain N2805-1, Live
Target species:
-
Cattle
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Mycoplasma bovis, strain N2805-1, Live2200000.00/Colony forming unit1.00unit(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AE05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Cardboard box containing 1 vial with 10 doses of lyophilisate and 1 vial with 20 ml solvent.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V661554
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0454/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.